(Press-News.org) London (July 05 2012 ) -- European experts in cardiovascular medicine will today gather at a two day symposium to address the national agenda on cardiovascular disease prevention, held at Imperial College London and sponsored by leading independent academic and professional publisher SAGE.
One session at the conference, chaired by Professors Joep Perk and David Wood will focus on the new 2012 Joint European Societies' Guidelines on cardiovascular disease prevention in clinical practice, which will appear in August issue (volume 19, issue 4) of the European Society of Cardiology's European Journal of Preventive Cardiology, published by SAGE.
Our chances of succumbing to cardiovascular disease (CVD) are strongly connected to our lifestyles. Smoking, an unhealthy diet, physical inactivity, and stress can all take their toll. According to The World Health Organization (WHO), over three-quarters of all CVD mortality could be prevented with adequate lifestyle changes.
CVD prevention is a society-wide effort, and needs a co-ordinated set of actions at both public and individual level. Health experts use cardiovascular epidemiology and evidence based medicine to uncover the most effective paths to prevention.
In the new joint European Guidelines, healthcare providers will find answers to key questions including:
What is CVD prevention?
Why is it needed?
Who should benefit from it?
How can CVD prevention be applied?
When is the right moment to act?
Where should prevention programmes be provided and implemented?
According to the experts behind the review, atherosclerotic CVD (furring of the arteries) remains the leading cause of premature death worldwide. CVD affects both men and women; of all deaths that occur before age 75 in Europe, 42% are due to CVD in women and 38% in men.
Prevention works. Over 50% of the reductions seen in coronary heart disease mortality relate to changes in risk factors, and 40% to improved treatments. This is a lifelong endeavour – we should begin efforts to prevent CVD from birth – if not before.
In terms of prevention, the experts say it's not just those most at risk that should be targeted. Education programmes aimed at the entire population are still needed. Even though there are some gaps in our understanding, there is ample evidence to justify intensive public health and individual preventive efforts.
We still need to better understand why both populations and individuals change their behaviour – exactly how changes in behaviour translate into changes in disease patterns is not always understood. More research, including research that goes right back to foetal development, is needed to better prevent CVD. We still don't know whether preventative measures can help us to completely avoid CVD, or whether these efforts merely delay its onset. We also need more data on CVD morbidity and mortality throughout the world.
This version of the joint guidelines updates the previous one issued in 2007. There is a greater focus on new scientific knowledge, and grading systems are deployed, which allow more evidence-based recommendations to be adapted to clinical practice's requirements.
The Fifth Joint Task Force (JTF) of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice, made up of representatives of nine societies plus invited experts, developed the new guidelines. The European Association for Cardiovascular Prevention & Rehabilitation (EACPR) also contributed. Experts from the nine organizations performed a comprehensive review and a critical evaluation of diagnostic and therapeutic procedures, including assessment of the risk benefit ratio. The level of evidence and the strength of recommendation of particular treatment options were weighed and graded according to ESC recommendations.
"The authors of the guidelines hope that this document will advocate a real partnership among politicians, physicians, allied health personnel, scientific associations, heart foundations, voluntary organizations, and consumers' associations. Using the complete spectrum of evidence in medicine from experimental trials to observations in populations, the aim is to foster both health promotion at the population level and primary and cardiovascular prevention at the clinical level" the JTF concluded.
###
Further information:
All relevant reference material is available on the dedicated CVD Prevention Guidelines page of the ESC Website. A one-page summary of all strong recommendations is provided, the essential messages and gaps in evidence, an educational slide-set as well as a pocket version for daily clinical use.
"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)"published today, 05 July 2012 in European Journal of Preventive Cardiology.
The guidelines will be free to access for a limited time here: http://ejpc.sagepub.com and are also downloadable from http://www.escardio.org.
END
Feelings of anxiety very effectively prevent people from getting into situations that are too dangerous. Those who have had a terrible experience initially tend to avoid the place of tragedy out of fear. If no other oppressive situation arises, normally the symptoms of fear gradually subside. "The memory of the terrible events is not just erased." states first author, PD Dr. Andras Bilkei Gorzo, from the Institute for Molecular Psychiatry at the University of Bonn. "Those impacted learn rather via an active learning process that they no longer need to be afraid because ...
Frequently recommended in weight-loss diets, dietary proteins have proven effectiveness thanks to their appetite-suppressing effects. A team led by Gilles Mithieux, Director of Inserm's Unit 855 "Nutrition and the Brain" in Lyon, has managed to explain the biological mechanisms behind these properties. The researchers describe in detail the chain reactions triggered by digesting proteins, sending a 'satiety' message to the brain long after a meal. Their results, published on 5 July in the Cell review, will make it possible envisage improved care for obese or overweight ...
Bethesda, MD—If you're concerned about losing your hearing because of noise exposure (earbud deafness syndrome), a new discovery published online in the FASEB Journal offers some hope. That's because scientists from Germany and Canada show that the protein, AMPK, which protects cells during a lack of energy, also activates a channel protein in the cell membrane that allows potassium to leave the cell. This activity is important because this mechanism helps protect sensory cells in the inner ear from permanent damage following acoustic noise exposure. This information could ...
On this July 4th week, U.S. beachgoers are thronging their way to seaside resorts and parks to celebrate with holiday fireworks.
Across the horizon and miles out to sea toward the north, the Atlantic Ocean's own spring and summer ritual is unfolding: the blooming of countless microscopic plant plankton, or phytoplankton.
In what's known as the North Atlantic Bloom, an immense number of phytoplankton burst into color, first "greening" then "whitening" the sea as one species follows another.
In research results published in this week's issue of the journal Science, ...
Copenhagen, Denmark – A landmark conference has agreed key priorities for harnessing the power of information technologies and social networks to understand better the workings of life on Earth, focussing on how biodiversity can continue to sustain human lives and livelihoods.
The Global Biodiversity Informatics Conference (GBIC), gathering some 100 experts from around the world from 2-4 July, identified critical areas in which greater investment and better coordination could give society much better, innovative tools to monitor and manage biological resources. These ...
July 4, 2012, was an historic day in science with researchers at CERN (European Organization for Nuclear Research) announcing the discovery of a new particle that is "consistent with the Higgs boson." It was also an historic day for the University of Rochester. Not only was one of its faculty members an originator of the theory for the Higgs mechanism and the Higgs boson, three of its scientists worked on one of the experiments that led to the CERN discovery.
Physicist Carl Hagen's 1964 article Global Conservation Laws and Massless Particles, co-written by Gerald Guralnik ...
BOSTON, MA—Researchers at Brigham and Women's Hospital (BWH) have discovered a new vaccine candidate for the bacterium Pseudomonas aeruginosa taking advantage of a new mechanism of immunity.
The study was published online in the American Journal of Respiratory and Critical Care Medicine on June 21, 2012.
Pseudomonas aeruginosa is a leading cause of hospital-acquired infections, particularly in patients on respirators, where it can cause so-called ventilator-associated pneumonia, which carries a very high mortality rate. Pseudomonas also causes lung infections in people ...
Bethesda, MD—In what could be a breakthrough in the practical application of epigenetic science, U.K. scientists used human tissue samples to discover that those with osteoarthritis have a signature epigenetic change (DNA methylation) responsible for switching on and off a gene that produces a destructive enzyme called MMP13. This enzyme is known to play a role in the destruction of joint cartilage, making MMP13 and the epigenetic changes that lead to its increased levels, prime targets for osteoarthritis drug development. In addition to offering a new epigenetic path toward ...
NEW YORK, July 6, 2012 -- Ben-Gurion University of the Negev (BGU) undergraduate students have developed a new privacy solution for Facebook. The Social Privacy Protector (SPP) can help parents adjust their children's profiles in one click, prevent criminals from garnering valuable personal information and keep teens safe from pedophiles.
The SPP "app" has multiple levels of protection, but the most important component reviews a user's friends list in seconds to identify which have few or no mutual links and might be "fake" profiles. The app analyzes each friend and ...
Bethesda, MD—Whether from surgery or battle wounds, ugly scars can affect body and mind. Now a new research report appearing online in the FASEB Journal offers a new strategy to reduce or eliminate scars on the skin. Specifically, scientists from NYU describe how agents that block receptors for adenosine (a molecule generated from ATP which is used by the body to provide energy to muscles) can be applied topically to healing wounds to reduce scar size, yielding skin that feels more like the original, unscarred skin.
"Scars can be disfiguring and, if extensive enough, ...
